Loss of activity of human CAR-T cells against tumor cells in NSG mice or humans was associated with expression of multiple inhibitory receptors including PD-1, BTLA, LAG3, TIM3, and 2B4 [125, 126]. This evidence concerns the gene BTLA and neoplasm.